(the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio ...
Q3 2025 net product revenues grew to $14.3 million; Q3 2025 total net product revenues were $56.8 million Operational pilot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback